TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
8 hedge funds and large institutions have $1.39M invested in TIANYIN PHARMACEUTICAL in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
39% more capital invested
Capital invested by funds: $1M → $1.39M (+$388K)
14% more funds holding
Funds holding: 7 → 8 (+1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
California Public Employees Retirement System
Sacramento,
California
|
+$183K |
| 2 |
Renaissance Technologies
New York
|
+$12.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$7.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Pope Asset Management
Memphis,
Tennessee
|
-$23.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9K |
| 3 |
BWFA
Baltimore-Washington Financial Advisors
Columbia,
Maryland
|
-$3K |
| 4 |
RIM
Regent Investment Management
Louisville,
Kentucky
|
-$2.74K |
TPI Hedge Fund Activity: Q4 2014 in Review
8 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q4 2014, worth a combined $1.39M — up 39% from $1M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TPI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was California Public Employees Retirement System, opening a new position worth an estimated $183K. The largest seller was Pope Asset Management, cutting an estimated $23.1K.
- 8 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q4 2014, up from 7 in Q3 2014.
- Funds reported $1.39M of TIANYIN PHARMACEUTICAL stock for Q4 2014, up 39% quarter-over-quarter.
- 4 funds opened new TIANYIN PHARMACEUTICAL positions in Q4 2014 and 2 closed out, a net change of +2 holders.
- The largest TIANYIN PHARMACEUTICAL buyer in Q4 2014 was California Public Employees Retirement System, an estimated $183K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q4 2014 was Pope Asset Management, an estimated $23.1K sold.
Based on aggregated 13F filings for Q4 2014.